Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 9
- Registration Number
- NCT00052494
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- National Cancer Centre, Singapore
- Target Recruit Count
- 200
- Registration Number
- NCT00003576
- Locations
- 🇸🇬
National Cancer Centre - Singapore, Singapore, Singapore
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-04-06
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 45
- Registration Number
- NCT00005049
- Locations
- 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-04-06
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00004103
- Locations
- 🇺🇸
NYU Cancer Institute at New York University Medical Center, New York, New York, United States
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-04-05
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00010023
- Locations
- 🇺🇸
NYU Cancer Institute at New York University Medical Center, New York, New York, United States
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 36
- Registration Number
- NCT00003332
- Locations
- 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT00002472
- Locations
- 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 33
- Registration Number
- NCT00003309
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States
🇺🇸Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-07-09
- Target Recruit Count
- 564
- Registration Number
- NCT00002839
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
🇮🇱Rambam Medical Center, Haifa, Israel
🇧🇪Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 682
- Registration Number
- NCT00003596
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States
🇺🇸Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.